Phenotypic and Genotypic Characterization of Candida auris, an Emerging Pathogen Isolated from Blood

  • Sathyakamala Ravichandran Postgraduate Tutor, Department of Microbiology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Tamil Nadu, India.
  • Priyadarshini Shanmugam Professor and Head, Department of Microbiology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Tamil Nadu, India.
  • Ambujavalli Balakrishnan Thayikkannu Assistant Professor, Department of Microbiology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Tamil Nadu, India.
Keywords: Candida auris, Candidemia, PCR-RFLP, AFST, Virulence


Introduction: Candida auris has been reported from various health care settings and has recently gained importance because of its intrinsic resistance to many classes of antifungal agents and to disinfection. The outbreak potential and high mortality associated with Candida auris infection reinforces the need for speciation. Routine conventional methods are cumbersome and automated systems are unable to confirm up to species level.
Materials and Methods: Candida auris isolates from consecutive non-repetitive blood cultures over a 1-year period were speciated based on phenotypic, physiological and biochemical tests and VITEK. Molecular confirmation was done by PCR-RFLP and MALDI-TOF. Anti- fungal susceptibility test was performed according to CLSI guidelines (2021), using suitable controls. Virulence factors such as production of Hemolysin, Phospholipase, Esterase and Bio-film production were demonstrated. RT-PCR was used to screen the COVID-19 status using SD-Biosensor kit. Baseline data and clinical history were collected and analysed.
Results: Of 3632 blood cultures (0.77%), 28 Candida sp. were isolated including 9 Candida auris, (9/28, 32.14%). Of these 8 were from COVID-19 positive patients (88.89%), while 1 was from COVID-19 negative patient (11.11%). Two patients survived, while the remaining 7 patients succumbed to the disease.
Conclusion: The increasing incidence of Candidiasis especially during the COVID-19 pandemic has raised the concern for early speciation. Through multi-modal strategies such as quick and correct identification, active surveillance, guided reporting, stringent infection control measures and correct use of anti-fungals through proper susceptibility testing, we can prevent the occurrence and spread of new Candida auris cases in the future.

How to cite this article:
Ravichandran S, Shanmugam P, Thayikkannu AB. Phenotypic and Genotypic Characterization of Candida Auris, an Emerging Pathogen Isolated from Blood. J Commun Dis. 2022;54(4):54-61.



Chander J. Textbook of medical mycology. JP Medical Ltd. 2017;30. [Google Scholar]

Vasilyeva N, Kruglov A, Pchelin IM. The first Russian case of candidaemia due to Candida auris. In 28th European Conference of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain 2018;21:21-4. [Google Scholar]

Bhat KS, Kisku KH, Kanungo R. Candida auris candidemia an emerging threat. A case report and mini review of the literature. Journal of Current Research in Scientific Medicine. 2019;1;5(2):110. [Google Scholar]

Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India. Emerg Infect Dis. 2020;26(11):2694-6. [PubMed] [Google Scholar]

Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug resistant Candida auris infections in critically ill coronavirus disease patients, India. Emerg Infect Dis. 2020;26(11):2694-6. [PubMed] [Google Scholar]

De Almeida JN Jr, Francisco EC, Hagen F, Brandão IB, Pereira FM, Presta Dias PH, de Miranda Costa MM, de Souza Jordão RT, de Groot T, Colombo AL. Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit. J Fungi (Basel). 2021;7(3):220. [PubMed] [Google Scholar]

Chowdhary A, Sharma A. The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic. J Glob Antimicrob Resist. 2020;22:175-6. [PubMed] [Google Scholar]

Villanueva-Lozano H, Treviño-Rangel RJ, González GM, Ramírez-Elizondo MT, Lara-Medrano R, Aleman-Bocanegra MC, Guajardo-Lara CE, Gaona-Chávez N, Castilleja-Leal F, Torre-Amione G, Martínez-Reséndez MF. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect. 2021;27(5):813-6. [PubMed] [Google Scholar]

Sathyapalan DT, Antony R, Nampoothiri V, Kumar A, Shashindran N, James J, Thomas J, Prasanna P, Sudhir AS, Philip JM, Edathadathil F, Prabhu B, Singh S, Moni M. Evaluating the measures taken to contain a Candida auris outbreak in a tertiary care hospital in South India: an outbreak investigational study. BMC Infect Dis. 2021;21(1):425. [PubMed] [Google Scholar]

Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6:69. [PubMed] [Google Scholar]

National Committee for Clinical Laboratory Standards. Method for antifungal disk diffusion susceptibility testing of yeasts: approved guideline M44-A2. Clinical and Laboratory Standards Institute, Wayne, PA, USA. 2004.

Kenters N, Kiernan M, Chowdhary A, Denning DW, Pemán J, Saris K, Schelenz S, Tartari E, Widmer A, Meis JF, Voss A. Control of Candida auris in healthcare institutions: Outcome of an International society for antimicrobial chemotherapy expert meeting. Int J Antimicrob Agents. 2019;54(4):400-6. [PubMed] [Google Scholar]

Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73(4):891-9. [PubMed] [Google Scholar]

Chow NA, Muñoz JF, Gade L, Berkow EL, Li X, Welsh RM, Forsberg K, Lockhart SR, Adam R, Alanio A, Alastruey-Izquierdo A, Althawadi S, Araúz AB, Ben-Ami R, Bharat A, Calvo B, Desnos-Ollivier M, Escandón P, Gardam D, Gunturu R, Heath CH, Kurzai O, Martin R, Litvintseva AP, Cuomo CA. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. mBio. 2020;11(2):e03364-19. [PubMed] [Google Scholar]

Vijayakumar R, Giri S, Kindo AJ. Molecular species identification of Candida from blood samples of intensive care unit patients by polymerase chain reaction - restricted fragment length polymorphism. J Lab Physicians. 2012;4(1):1-4. [PubMed] [Google Scholar]

Kumar J, Eilertson B, Cadnum JL, Whitlow CS, Jencson AL, Safdar N, Krein SL, Tanner WD, Mayer J, Samore MH, Donskey CJ. Environmental contamination with Candida species in multiple hospitals including a tertiary care hospital with a candida auris outbreak. Pathog Immun. 2019;4(2):260-70. [PubMed] [Google Scholar]

Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19:1670-3. [PubMed] [Google Scholar]

Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization–time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol. 2015;53:1823-30. [PubMed] [Google Scholar]

Belkin A, Gazit Z, Keller N, Ben-Ami R, Wieder-Finesod A, Novikov A, Rahav G, Brosh-Nissimov T. Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017. Emerg Infect Dis. 2018;24(4):801-4. [PubMed] [Google Scholar]

Ninan MM, Sahni RD, Chacko B, Balaji V, Michael JS. Candida auris: Clinical profile, diagnostic challenge and susceptibility pattern: Experience from a tertiary care centre in South India. J Glob Antimicrob Resist. 2020;21:181-5. [PubMed] [Google Scholar]

CLSI. Performance standards for antifungal susceptibility testing of yeasts. 2nd ed. CLSI supplement M60. Wayne, PA: Clinical and Laboratory Standards Institute. 2020.

Das S, Singh S, Tawde Y, Chakrabarti A, Rudramurthy SM, Kaur H, Shankarnarayan SA, Ghosh A. A selective medium for isolation and detection of Candida auris, an emerging pathogen. J Clin Microbiol. 2021;59(2):e00326-20. [PubMed] [Google Scholar]